SCHEMBL5755383

SCHEMBL5755383

COC(=O)c1cc([N+](=O)[O-])cc2c(O)nc(Nc3ccc(F)cc3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 1/20 0.42
▸ PIK3CB P42338 1/20 0.42
▸ PIK3CG P48736 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ PIN1 Q13526 4/20 0.41
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ MET P08581 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CTSV O60911 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ KCNH3 Q9ULD8 2/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5753186 0.89 PIN1 (0.45) PIK3CAPIK3CBPIK3CGL3MBTL1PIN1
SCHEMBL14461134 0.87 PIN1 (0.40) PIK3CAPIK3CBPIK3CGL3MBTL1PIN1
SCHEMBL5755610 0.86 MEN1 (0.47) PIK3CAPIK3CBPIK3CGL3MBTL1PIN1
SCHEMBL12264711 0.82 NQO2 (0.41) PIK3CAPIK3CBPIK3CGL3MBTL1PIN1
SCHEMBL12264712 0.82 PIN1 (0.40) PIK3CAPIK3CBPIK3CGL3MBTL1PIN1
SCHEMBL5754880 0.79 ALDH1A1 (0.38) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5756395 0.77 HDAC3 (0.40) PIN1MEN1KMT2ASMN1; SMN2RXFP1
SCHEMBL5755645 0.77 KMT2A (0.40) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL5753538 0.74 MAPT (0.44) MEN1KMT2ASMN1; SMN2RXFP1ALDH1A1
SCHEMBL5754027 0.74 MEN1 (0.49) PIK3CAPIK3CBPIK3CGL3MBTL1PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218358-B1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2006-09-13 — — EP disclosed
EP-1218358-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
US-6399603-B1 QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY ASTRAZENECA AB (SE) 2002-06-04 — — US disclosed
WO-2001021598-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback